Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.46 USD | -3.89% |
|
-3.06% | +183.96% |
06-24 | Novavax applies to the EMA for its Covid vaccine from age 12 | CF |
06-24 | Novavax Seeks EU Authorization for Updated Covid-19 Vaccine | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+183.96% | 1.97B | |
+28.42% | 52.73B | |
+37.49% | 39B | |
-9.25% | 38.52B | |
+28.88% | 30.38B | |
-12.26% | 26.39B | |
+11.84% | 26.08B | |
+45.92% | 14.15B | |
+32.92% | 12.6B | |
-5.46% | 11.51B |
- Stock Market
- Equities
- NVAX Stock
- News Novavax, Inc.
- Transcript : Novavax, Inc., Q1 2015 Earnings Call, May 07, 2015